Fucoidan-functionalized polysaccharide submicroparticles loaded with alteplase for efficient targeted thrombolytic therapy
A Zenych, C Jacqmarcq, R Aid, L Fournier… - Biomaterials, 2021 - Elsevier
Intravenous administration of fibrinolytic drugs is the standard treatment of acute thrombotic
diseases. However, current fibrinolytics exhibit limited clinical efficacy because of their short …
diseases. However, current fibrinolytics exhibit limited clinical efficacy because of their short …
Fucoidan-functionalized polysaccharide submicroparticles loaded with alteplase for efficient targeted thrombolytic therapy
A Zenych, C Jacqmarcq, R Aid, L Fournier… - Biomaterials, 2021 - hal.science
Intravenous administration of fibrinolytic drugs is the standard treatment of acute thrombotic
diseases. However, current fibrinolytics exhibit limited clinical efficacy because of their short …
diseases. However, current fibrinolytics exhibit limited clinical efficacy because of their short …
Fucoidan-functionalized polysaccharide submicroparticles loaded with alteplase for efficient targeted thrombolytic therapy
A Zenych, C Jacqmarcq, R Aid… - …, 2021 - sorbonne-paris-nord.hal.science
Intravenous administration of fibrinolytic drugs is the standard treatment of acute thrombotic
diseases. However, current fibrinolytics exhibit limited clinical efficacy because of their short …
diseases. However, current fibrinolytics exhibit limited clinical efficacy because of their short …
Fucoidan-functionalized polysaccharide submicroparticles loaded with alteplase for efficient targeted thrombolytic therapy.
A Zenych, C Jacqmarcq, R Aid, L Fournier, FR LM… - Biomaterials, 2021 - europepmc.org
Intravenous administration of fibrinolytic drugs is the standard treatment of acute thrombotic
diseases. However, current fibrinolytics exhibit limited clinical efficacy because of their short …
diseases. However, current fibrinolytics exhibit limited clinical efficacy because of their short …
Fucoidan-functionalized polysaccharide submicroparticles loaded with alteplase for efficient targeted thrombolytic therapy
A Zenych, C Jacqmarcq, R Aid, L Fournier… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Intravenous administration of fibrinolytic drugs is the standard treatment of acute thrombotic
diseases. However, current fibrinolytics exhibit limited clinical efficacy because of their short …
diseases. However, current fibrinolytics exhibit limited clinical efficacy because of their short …
[PDF][PDF] Fucoidan-functionalized polysaccharide submicroparticles loaded with alteplase for efficient targeted thrombolytic therapy
A Zenych, C Jacqmarcq, R Aid, L Fournier… - hal.science
Intravenous administration of fibrinolytic drugs is the standard treatment of acute thrombotic
diseases. However, current fibrinolytics exhibit limited clinical efficacy because of their short …
diseases. However, current fibrinolytics exhibit limited clinical efficacy because of their short …